Gene · 11255
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development. | Transl Psychiatry | 2026 | 41611659 | PubTator, text mining | PubMed |
| Multitargeted Aza-Arylcarboxamides for Neurodegenerative Diseases: Potent Histamine H3 Receptor Ligands with Anticholinesterase and Metal-Chelating Activities. | ACS Chem Neurosci | 2026 | 41607197 | PubTator, text mining | PubMed |
| Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds-Histamine H3 Receptor Ligands and MAO-B Inhibitors. | Int J Mol Sci | 2026 | 41596234 | PubTator, text mining | PubMed |
| In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis. | Sci Transl Med | 2026 | 41564155 | PubTator, text mining | PubMed |
| Differential Expression of Histamine H3 Receptor In Healthy, Preneoplastic, and Tumoral Pancreatic Tissue: A Pilot Study. | J Histochem Cytochem | 2026 | 41479137 | PubTator, text mining | PubMed |
| Activity-restoring mutations in the histamine H3 receptor increase constitutive activity and reduce structural stability. | Protein Sci | 2026 | 41427659 | PubTator, text mining | PubMed |
| Efficacy and Safety of Pitolisant for Excessive Daytime Sleepiness in Narcolepsy and Obstructive Sleep Apnea: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Ann Pharmacother | 2026 | 41324388 | PubTator, text mining | PubMed |
| Biased histamine signaling selectively gates fat preference. | Neuron | 2026 | 41308645 | PubTator, text mining | PubMed |
| Targeting glioblastoma with hybrid H3R antagonists with piperidinylpropoxy and trimethoxychalcone motifs results in broad oncosuppressive effects. | J Drug Target | 2026 | 41070924 | PubTator, text mining | PubMed |
| Decoding ligand recognition and constitutive activation of histamine H3 and H4 receptors. | Acta Pharmacol Sin | 2026 | 40877594 | PubTator, text mining | PubMed |
| Characterization of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in Glioblastoma. | Pharmaceuticals (Basel) | 2025 | 41599622 | PubTator, text mining | PubMed |
| Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma. | Pharmaceutics | 2025 | 41471109 | PubTator, text mining | PubMed |
| Reciprocal regulation of the H3 histamine receptor in Rett syndrome and MECP2 Duplication syndrome: implications for therapeutic development. | bioRxiv | 2025 | 41278653 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors. | Pharmaceuticals (Basel) | 2025 | 41011265 | PubTator, text mining | PubMed |
| Brain histaminergic system: An emerging target for the treatment of feeding and eating-related disorders. | Pharmacol Res | 2025 | 40946942 | PubTator, text mining | PubMed |
| Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans. | Mol Imaging Biol | 2025 | 40938339 | PubTator, text mining | PubMed |
| ACtriplet: An improved deep learning model for activity cliffs prediction by in tegrating triplet loss and pre-training. | J Pharm Anal | 2025 | 40893440 | PubTator, text mining | PubMed |
| The future of pharmaceuticals: Artificial intelligence in drug discovery and development. | J Pharm Anal | 2025 | 40893437 | PubTator, text mining | PubMed |
| Histamine as a mediator of cross-talk between human lung mast cells and macrophages. | Sci Rep | 2025 | 40885833 | PubTator, text mining | PubMed |
| Letter to the editor regarding "Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation". | Biomed Pharmacother | 2025 | 40774022 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11255/papers?page=2